THU0620 on Demand Use of Anakinra for the Attacks of Familial Mediterranean Fever (FMF)

doi 10.1136/annrheumdis-2018-eular.7198
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Update on the Management of Colchicine Resistant Familial Mediterranean Fever (FMF)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Two Case With Different Clinical Findings: Familial Mediterranean Fever (Fmf)

The Journal of Tepecik Education and Research Hospital
2008English

Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

How Long Is the Diagnosis of Familial Mediterranean Fever (FMF) Delayed in a Region Where FMF Is Common in Turkey?

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Familial Mediterranean Fever Patient With Onset of Attacks at the Age of Seventies

Journal of Clinical and Analytical Medicine
Medicine
2016English

Assessment of Effectiveness of Anakinra and Canakinumab in Patients With Colchicine-Resistant/Unresponsive Familial Mediterranean Fever

Advances in Rheumatology
Rheumatology
2020English

P01-031 – Anakinra for Colchicine Resistant FMF

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Familial Mediterranean Fever (FMF) With Proteinuria: Clinical Features, Histology, Predictors, and Prognosis in a Cohort of 25 Patients

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

The Role of Genotype in Familial Mediterranean Fever

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy